Warning (512): /home/pharma/website/current/cakephp/app/pharmalicensing/tmp/cache/ is not writable [CORE/cake/libs/cache/file.php, line 267]
Success Fee
RSS Feeds
Search

Success Fee

Success Fee

The Success Fee is a compensation formula applied at the back-end of all successfully completed agreements effectuated by our clients based on an introduction through Innovaro Pharmalicensing's Partnering Search & Profiling services.

The Success Fee will be calculated based on the formula below (in US$):

Partnering Search

  • 8% of the first million dollars US involved in the transaction
  • 6% of the second million
  • 4% of the third million
  • 2% of everything thereafter (above 3 million dollars US)

Profiling

  • 4% of the first million dollars US involved in the transaction
  • 3% of the second million
  • 2% of the third million
  • 1% of everything thereafter (above 3 million dollars US)

The Success Fee is applied by Innovaro Pharmalicensing based only on a successfully completed agreement between our client and a third party organisation introduced to the client by Innovaro Pharmalicensing. Payment shall be made to Innovaro Pharmalicensing in the same manner and time that the payments are exchanged between our client and the third party.


Partnering Search - Check how we can assist you.

What would be the Success Fee for $10,000,000 transaction?

Partnering Search

The simple answer is $320,000.

And this is how we calculate the Success Fee:

Transaction value % Success Fee
$1,000,000 8% $80,000
$1,000,000 6% $60,000
$1,000,000 4% $40,000
$7,000,000 2% $140,000
$10,000,000   $320,000

A few other examples:

Transaction value Success Fee Overall %
$10,000,000 $320,000 3.2%
$15,000,000 $420,000 2.8%
$20,000,000 $520,000 2.6%
$25,000,000 $620,000 2.48%

Profiling

And for Profiling it is $160,000.

And this is how we calculate the Success Fee in this case:

Transaction value % Success Fee
$1,000,000 4% $40,000
$1,000,000 3% $30,000
$1,000,000 2% $20,000
$7,000,000 1% $70,000
$10,000,000   $160,000

A few other examples:

Transaction value Success Fee Overall %
$10,000,000 $160,000 1.6%
$15,000,000 $210,000 1.4%
$20,000,000 $260,000 1.3%
$25,000,000 $310,000 1.24%

Frequently asked questions about Success Fee:

Do we have to pay a Success Fee on all deals that we do in the future?
No, the Success Fee is only applicable to those agreements which have been actively effectuated by an introduction to the third-party partner organisation through Innovaro Pharmalicensing services.

At what point is the Success Fee payable? Do we have to pay the Success Fee at the time we execute an agreement with the third party?
No, you would not need to pay the Success Fee at the time you execute the agreement with the third-party. The Success Fee will be payable at the point when payments are exchanged between you and the third-party organisation.

If we execute an agreement with a third party but the agreement collapses before any payments are exchanged do we still have to pay the Success Fee?
No, under these circumstances there would be no Success Fee applicable because no payments would have been exchanged between you and the third party. At this stage we would be happy to work with you to identify alternative partners with whom you can work.

To what elements of the agreement would the Success Fee be applicable?
The Success Fee would be applicable to all elements contained in the agreement where payments would be exchanged.

These would include, but not be limited to, any up-front payments, milestones and ongoing royalty payments for transactions through the partnering.

Check now!

Transaction value
million USD
Partnering Search
Profiling
Submit
The Success Fee
$320,000 (3.2%)

Number in the brackets shows percentage of the Success Fee to overall transaction value.

Contact us

For further information contact our team on +44 1904 520460, via email or request a callback.

© Copyright 1998-2012 Innovaro Europe Ltd Innovaro Corporation All rights reserved. Terms and Conditions | Contact us

(website) 38 queries took 272 ms
NrQueryErrorAffectedNum. rowsTook (ms)
1DESCRIBE `sites`552
2DESCRIBE `user`24242
3DESCRIBE `condet`17175
4DESCRIBE `countrycode`4414
5DESCRIBE `company`27271
6DESCRIBE `person`15153
7DESCRIBE `account`292911
8DESCRIBE `product_legacy`665
9DESCRIBE `sales_people`664
10DESCRIBE `profile`14142
11DESCRIBE `currencies`776
12DESCRIBE `update_rec`775
13DESCRIBE `dms_companies`262614
14DESCRIBE `dms_releases`101010
15DESCRIBE `dms_categories`445
16DESCRIBE `dms_clinical_areas`447
17DESCRIBE `dms_categories_dms_releases`222
18DESCRIBE `dms_clinical_areas_dms_releases`224
19DESCRIBE `dms_releases_sites`557
20DESCRIBE `licopp`23236
21DESCRIBE `development_statuses`559
22DESCRIBE `category`14145
23DESCRIBE `categories_sites`5512
24DESCRIBE `categorisation`881
25DESCRIBE `licopps_sites`336
26DESCRIBE `service`151519
27DESCRIBE `enquiry`14149
28DESCRIBE `module_types`667
29DESCRIBE `press_release`131314
30DESCRIBE `press_releases_sites`555
31DESCRIBE `story`121211
32DESCRIBE `sites_stories`5510
33DESCRIBE `story_assoc`443
34DESCRIBE `companies_sites`336
35DESCRIBE `categories_users`2216
36DESCRIBE `authority`332
37DESCRIBE `sites_users`554
38SELECT `Site`.`id`, `Site`.`name`, `Site`.`email_domain`, `Site`.`short_name`, `Site`.`brand` FROM `sites` AS `Site` WHERE `Site`.`id` = 1 LIMIT 11118